Hims & Hers Health (HIMS) Liabilities and Shareholders Equity (2019 - 2025)
Hims & Hers Health's Liabilities and Shareholders Equity history spans 7 years, with the latest figure at $2.2 billion for Q3 2025.
- For Q3 2025, Liabilities and Shareholders Equity rose 270.82% year-over-year to $2.2 billion; the TTM value through Dec 2025 reached $5.0 billion, up 123.49%, while the annual FY2024 figure was $707.5 million, 60.37% up from the prior year.
- Liabilities and Shareholders Equity for Q3 2025 was $2.2 billion at Hims & Hers Health, up from $1.9 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $2.2 billion in Q3 2025 and bottomed at $345.9 million in Q1 2021.
- The 5-year median for Liabilities and Shareholders Equity is $430.9 million (2021), against an average of $672.5 million.
- The largest annual shift saw Liabilities and Shareholders Equity fell 12.9% in 2022 before it skyrocketed 290.76% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $420.6 million in 2021, then decreased by 12.9% to $366.3 million in 2022, then grew by 20.43% to $441.2 million in 2023, then skyrocketed by 60.37% to $707.5 million in 2024, then surged by 215.64% to $2.2 billion in 2025.
- Per Business Quant, the three most recent readings for HIMS's Liabilities and Shareholders Equity are $2.2 billion (Q3 2025), $1.9 billion (Q2 2025), and $891.7 million (Q1 2025).